Genoptic goes to Europe
NanoGEN microchips - revolutionising electronics
Intelligent micro solutions for macro applications
Genoptic is a Canadian research and development company in collaboration with Canadian universities, specialising in nano-optoelectronics. We provide technological advances in industries such as lighting and display, solar energy, medical technology, indoor agriculture and for the Internet (IoT), meaning for all devices equipped with sensors, software and other technologies.
The Canadian Patent Powerhouse
NanoGEN chips - are critical to shaping the future of technology and various industries, including space exploration, healthcare and artificial intelligence. Genoptic has its own research department for the development of artificial intelligence.
The Canadian government has appointed Genoptic LED Inc. as a strategic partner for the critical infrastructure sector
- 125 patents registered worldwide in 18 patent families
- Patents from in-house AI research
Quality in every chip, every product and every solar panel worldwide
Genoptic Europe was founded in Calgary to serve the European solar market, which is larger than the combined US and Canadian market of 370 million people due to its population of 450 million. Genoptic Europe's first production line is being built at the parent company's site in Calgary, Alberta, to develop and serve the European market.
The first orders for Europe are expected from the Ukrainian government. Thanks to Genoptic's pioneering technology, it is possible to build smaller solar power plants across the country without complications. Funds from the EU's reconstruction programme are being used for this purpose. A plot of land in Luxembourg has been reserved for the construction of the first production facility in Europe. In addition to a department for the refinement of solar panels using the patented AI-controlled battery, a department for the production of AI-controlled lighting fixtures for vertical farming is planned.
1. Genoptic SolarTech of Canada has developed a proprietary patented solar energy harvesting system that integrates solar energy harvesting, housing, inverter, converter and energy storage system (battery) - ALL IN ONE.
2. Genoptic does not manufacture solar panels itself, but refines the solar panels produced by other manufacturers so that they are up to 40% superior to the competition.
The IMPACT Investment
We offer exclusively professional and institutional investors as well as high net worth individuals several consecutive investments in a RAIF from Luxembourg in Euro with a short term and an attractive return.
01
Planned term of 3 years. 10 % annual yield.
1st interest payment after 18 months.
Remainder bullet.
Warrants and shares for the planned IPO on request
02
Investments are made in the construction of a production facility via the fund by means of an investment loan that is collateralised by the assignment of all assets belonging to the project.
03
100% is invested. The fund costs (TER) of the investment are borne by the company
04
Alternatively, we offer club deals and customised solutions for institutional investors.
Through innovation, we strive to make the world a better place by developing and integrating smart and efficient electronic solutions to improve the way we live.
I am interested in the investment
‘Light Green Fund’ in accordance with SFDR Article 8
Saving electricity costs and reducing production costs will reduce our carbon footprint on earth in the long term.
When investing in Reserved Alternative Investment Funds (‘RAIF’) under Luxembourg law for institutional, semi-professional and professional investors, the investor enters into a long-term commitment that is associated with risks. In particular, a deterioration in the market environment and a deterioration in economic conditions are possible, up to and including total loss.